One of the challenges for the clinical translation of RNA interference (RNAi)-based therapies concerns the deposition of therapeutically effective doses of the nucleic acids, like siRNA, at a local tissue level without severe off-target effects. To address this issue, hydrogels can be used as matrices for the local and sustained release of the siRNA cargo. In this study, the formation of polyplexes based on siRNA and poly(2-dimethylaminoethyl methacrylate) (PDMAEMA)-based polymers was investigated, followed by their loading in a thermosensitive hydrogel to promote local siRNA release. A multifunctional NPD triblock copolymer consisting of a thermosensitive poly(N-isopropylacrylamide) (PNIPAM, N), a hydrophilic poly(ethylene glycol) (PEG, P)...
In this thesis, biodegradable non-viral polymeric nucleic acids delivery vectors were characterized ...
RNA interference (RNAi) is a powerful tool to treat diseases and elucidate target gene function. Pri...
Successful clinical use of synthetic siRNAs for gene therapy via a pathway called RNA interference (...
One of the challenges for the clinical translation of RNA interference (RNAi)-based therapies concer...
With the continuous progress in research and clinical success, nucleic acid-based therapeutics are e...
Here, we describe a concept for localized and long-term delivery of short interfering RNA (siRNA) us...
The local controlled release of siRNA is an attractive and rational strategy to enhance and extend t...
While siRNA has tremendous potential for therapeutic applications, advancement is limited by poor de...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
The potential of gene therapy for the treatment for chronic and life-threatening diseases has been s...
Long circulation, cell internalization, endosomal escape and small interfering RNA (siRNA) release t...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
The process of RNA interference (RNAi) is a natural phenomenon posttranscriptionally controlling gen...
The success of siRNA gene therapy requires the availability of safe and efficient delivery systems. ...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
In this thesis, biodegradable non-viral polymeric nucleic acids delivery vectors were characterized ...
RNA interference (RNAi) is a powerful tool to treat diseases and elucidate target gene function. Pri...
Successful clinical use of synthetic siRNAs for gene therapy via a pathway called RNA interference (...
One of the challenges for the clinical translation of RNA interference (RNAi)-based therapies concer...
With the continuous progress in research and clinical success, nucleic acid-based therapeutics are e...
Here, we describe a concept for localized and long-term delivery of short interfering RNA (siRNA) us...
The local controlled release of siRNA is an attractive and rational strategy to enhance and extend t...
While siRNA has tremendous potential for therapeutic applications, advancement is limited by poor de...
Success of synthetic interfering nucleic acids (siRNAs)-based therapy relies almost exclusively on e...
The potential of gene therapy for the treatment for chronic and life-threatening diseases has been s...
Long circulation, cell internalization, endosomal escape and small interfering RNA (siRNA) release t...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
The process of RNA interference (RNAi) is a natural phenomenon posttranscriptionally controlling gen...
The success of siRNA gene therapy requires the availability of safe and efficient delivery systems. ...
A critical need still remains for effective delivery of RNA interference (RNAi) therapeutics to targ...
In this thesis, biodegradable non-viral polymeric nucleic acids delivery vectors were characterized ...
RNA interference (RNAi) is a powerful tool to treat diseases and elucidate target gene function. Pri...
Successful clinical use of synthetic siRNAs for gene therapy via a pathway called RNA interference (...